ClariVest Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

ClariVest Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.32M	Hold	9,613	–	–	0.14%	207
2024 Q2	$1.32M	Buy	9,613 +19	+0.2%	+$2.62K	0.14%	207
2024 Q1	$1.32M	Sell	9,594 -79	-0.8%	-$10.9K	0.14%	216
2023 Q4	$1.27M	Sell	9,673 -3	-0%	-$395	0.07%	208
2023 Q3	$1.09M	Buy	9,676 +15	+0.2%	+$1.69K	0.06%	222
2023 Q2	$911K	Sell	9,661 -2,004	-17%	-$189K	0.05%	261
2023 Q1	$1.18M	Sell	11,665 -12	-0.1%	-$1.22K	0.05%	261
2022 Q4	$1.4M	Sell	11,677 -44	-0.4%	-$5.26K	0.07%	225
2022 Q3	$1.25M	Sell	11,721 -3,639	-24%	-$387K	0.06%	231
2022 Q2	$1.5M	Sell	15,360 -4,000	-21%	-$390K	0.07%	226
2022 Q1	$1.82M	Hold	19,360	–	–	0.07%	222
2021 Q4	$1.65M	Sell	19,360 -1,900	-9%	-$162K	0.05%	255
2021 Q3	$2.04M	Sell	21,260 -500	-2%	-$48K	0.07%	231
2021 Q2	$2.12M	Hold	21,760	–	–	0.07%	213
2021 Q1	$2.12M	Sell	21,760 -200	-0.9%	-$19.4K	0.07%	201
2020 Q4	$2.11M	Sell	21,960 -200	-0.9%	-$19.2K	0.07%	211
2020 Q3	$2.13M	Sell	22,160 -460	-2%	-$44.2K	0.07%	216
2020 Q2	$2.76M	Buy	22,620 +12,020	+113%	+$1.47M	0.08%	187
2020 Q1	$918K	Buy	+10,600	New	+$918K	0.03%	313
2018 Q2	–	Sell	-14,015	Closed	-$1.16M	–	756
2018 Q1	$1.16M	Buy	14,015 +100	+0.7%	+$8.3K	0.02%	407
2017 Q4	$1.08M	Sell	13,915 -15,398	-53%	-$1.19M	0.02%	416
2017 Q3	$1.8M	Hold	29,313	–	–	0.04%	298
2017 Q2	$1.35M	Sell	29,313 -20	-0.1%	-$920	0.03%	317
2017 Q1	$1.27M	Hold	29,333	–	–	0.03%	318
2016 Q4	$1.14M	Sell	29,333 -29	-0.1%	-$1.12K	0.03%	321
2016 Q3	$1.49M	Sell	29,362 -10,339	-26%	-$523K	0.04%	252
2016 Q2	$1.8M	Buy	39,701 +5,300	+15%	+$241K	0.05%	225
2016 Q1	$1.36M	Buy	34,401 +1,332	+4%	+$52.7K	0.04%	250
2015 Q4	$1.87M	Buy	33,069 +8,600	+35%	+$487K	0.05%	200
2015 Q3	$974K	Sell	24,469 -600	-2%	-$23.9K	0.03%	278
2015 Q2	$1.2M	Buy	25,069 +10,397	+71%	+$496K	0.04%	267
2015 Q1	$582K	Buy	+14,672	New	+$582K	0.02%	329